John F. Paolini Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

John F. Paolini is CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 61,324 shares of KNSA, which is worth approximately $2.47 Million. The most recent transaction as insider was on Oct 31, 2025, when has been sold 82,542 shares (Class A Ordinary Share) at a price of $37.14 per share, resulting in proceeds of $3,065,609. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.3K

6.83% 3M change

17.84% 12M change

Total Value Held $2.47 Million

John F. Paolini Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2025	SELL Open market or private sale	$3,065,609 $37.14 p/Share	82,542 Reduced 57.37%	61,324 Class A Ordinary Share
Oct 31 2025	BUY Exercise of conversion of derivative security	$521,665 $6.32 p/Share	82,542 Added 36.46%	143,866 Class A Ordinary Share
Sep 02 2025	SELL Payment of exercise price or tax liability	$28,623 $34.28 p/Share	835 Reduced 1.34%	61,324 Class A Ordinary Share
Sep 02 2025	BUY Exercise of conversion of derivative security	-	1,725 Added 2.7%	62,159 Class A Ordinary Share
Sep 01 2025	SELL Payment of exercise price or tax liability	$95,145 $33.49 p/Share	2,841 Reduced 4.49%	60,434 Class A Ordinary Share
Sep 01 2025	BUY Exercise of conversion of derivative security	-	5,872 Added 8.49%	63,275 Class A Ordinary Share
Aug 06 2025	SELL Open market or private sale	$954,528 $32.55 p/Share	29,325 Reduced 33.81%	57,403 Class A Ordinary Share

Aug 06 2025	BUY Exercise of conversion of derivative security	$111,435 $3.8 p/Share	29,325 Added 25.27%	86,728 Class A Ordinary Share
May 07 2025	SELL Open market or private sale	$5,400 $27.0 p/Share	200 Reduced 0.35%	57,403 Class A Ordinary Share
May 07 2025	BUY Exercise of conversion of derivative security	$760 $3.8 p/Share	200 Added 0.35%	57,603 Class A Ordinary Share
Apr 07 2025	SELL Payment of exercise price or tax liability	$14,885 $20.28 p/Share	734 Reduced 1.26%	57,403 Class A Ordinary Share
Apr 07 2025	BUY Exercise of conversion of derivative security	-	2,498 Added 4.12%	58,137 Class A Ordinary Share
Apr 01 2025	SELL Payment of exercise price or tax liability	$21,574 $21.77 p/Share	991 Reduced 1.75%	55,639 Class A Ordinary Share
Apr 01 2025	BUY Exercise of conversion of derivative security	-	3,374 Added 5.62%	56,630 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$11,463 $22.61 p/Share	507 Reduced 0.94%	53,256 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	1,725 Added 3.11%	53,763 Class A Ordinary Share
Sep 03 2024	SELL Open market or private sale	$1,615,014 $26.61 p/Share	60,692 Reduced 53.84%	52,038 Class A Ordinary Share
Sep 03 2024	BUY Exercise of conversion of derivative security	$171,758 $2.83 p/Share	60,692 Added 35.0%	112,730 Class A Ordinary Share
Sep 02 2024	SELL Payment of exercise price or tax liability	$22,327 $26.74 p/Share	835 Reduced 1.58%	52,038 Class A Ordinary Share
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,725 Added 3.16%	52,873 Class A Ordinary Share
Sep 01 2024	SELL Payment of exercise price or tax liability	$53,319 $26.74 p/Share	1,994 Reduced 3.75%	51,148 Class A Ordinary Share
Sep 01 2024	BUY Exercise of conversion of derivative security	-	4,121 Added 7.2%	53,142 Class A Ordinary Share
Jul 23 2024	SELL Open market or private sale	$584,980 $26.59 p/Share	22,000 Reduced 31.52%	47,803 Class A Ordinary Share
Jul 23 2024	BUY Exercise of conversion of derivative security	$40,920 $1.86 p/Share	22,000 Added 23.96%	69,803 Class A Ordinary Share
Apr 08 2024	SELL Payment of exercise price or tax liability	$13,120 $17.9 p/Share	733 Reduced 1.51%	47,803 Class A Common Share

JFP

John F. Paolini

CHIEF MEDICAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account